Background
Methods
Cell and culture conditions
Patients and samples
Gender | Age | Diagnosis | ALL typing | Chromosome analysis | Fusion gene | CDK6 | IC50 μM | |
---|---|---|---|---|---|---|---|---|
1 | F | 5 | ALL | B | 46, XX | Not detected | Positive | 2.14 |
2 | M | 4 | ALL, | B | 46, XY | TEL/AML1(+) | Positive | 1.73 |
3 | M | 3 | ALL | B | ALL/53–54, XY, +4, +6, +10, 12p+, +14, +17, +18, +20, +21 | Not detected | Positive | 14.68 |
4 | F | 4 | ALL | B | 46, XX | Not detected | Positive | 2.68 |
5 | F | 4 | ALL | B | ALL/53–55XX, +X, 1q+, +4, +6, +10, +11, +15, +17, +21 | Not detected | Positive | 11.52 |
Gender | Age | Diagnosis | AML typing | Chromosome analysis | Fusion gene | CDK6 | IC50 μM | |
---|---|---|---|---|---|---|---|---|
1 | F | 9 | AML | M4 | 46, XX | FLT3-ITD | Positive | 2.54 |
2 | F | 3 | AML | M4 | 46, XX, inv(16)(p13q22) | CBF/MYH11 | Positive | 8.46 |
3 | M | 4 | AML | M5b | 46, XY, −2, +10, t(10;10)(p13;q23) | MLL/AF10 | Positive | 1.94 |
4 | M | 12 | AML | M2a | 45, X, −Y, t(8;21)(q22;q22) | AML/ETO | Positive | 5.04 |
5 | F | 1 | AML | M4 | 46, XX, inv(16)(p13q22) | 46, XY, inv(16)(p13q22) | Positive | 2.98 |